Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).

John V. Reynolds,Shaun R. Preston,Brian P. ONeill,Maeve A. Lowery,Lene Baeksgaard,Thomas Crosby,Moya Cunningham,Sinead Cuffe,Gareth Griffiths,Rajarshi Roy,Stephen Falk,George B. Hanna,Frederick R. Bartlett,Imelda Parker,Alberto Alvarez-Iglesias,Magnus Nilsson,Guillaume Piessen,Signe Risum,Narayanasamy Ravi,Raymond S. McDermott

Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).

2021

4004Background: The optimum combination curative approach to locally advanced adenocarcinoma of the esophagus and esophago-gastric junction (AEG) is unknown. A key question is whether neoadjuvant m...

Keywords:

Adenocarcinoma
locally advanced
Medicine
Internal medicine
Oncology
Esophagus
Randomized controlled trial
perioperative chemotherapy
esophago gastric junction

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations